CD209-336A/G promotor polymorphism and its clinical associations in sickle cell disease Egyptian Pediatric patients
Objectives: To detect the frequency of CD209 A>G polymorphism in sickle cell disease (SCD) Egyptian patients and to evaluate the use of CD209 A>G polymorphism as a genetic predictor of SCD clinical heterogeneity. Methods: A total of 100 Egyptian children with SCD and 100 Egyptian controls were...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-06-01
|
Series: | Hematology/Oncology and Stem Cell Therapy |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1658387617301140 |